Biosimilars Conference 2010, Tuesday 16 and Wednesday 17 March 2010, Brussels, Belgium
Friday 16 October 2009 and Saturday 17 October 2009 , Brussels, Belgium
In an environment where resources are scarce and patents are fast expiring, effective product planning is paramount to ensuring the success of your organisation. Biologic drugs - noted as some of the most-expensive medicines - are major targets for cost savings. The developments facilitating follow-on biologics are gaining momentum, with significant commercial opportunities emerging. Significant barriers to entry exist in the biosimilars market. Initial investment and the need for specific expertise favour big players. Understanding of the marketplace is critical for success, acceptance by key stakeholders is crucial for market uptake of biosimilars. Achieving preferential reimbursement status through constant review of the pricing strategy is essential. Following on the success of our 3rd Biosimilars conference VIBpharma is proud to announce the 4th annual Biosimilars conference taking place on Tuesday 16 and Wednesday 17 March 2010 in Brussels, Belgium. Through a series of presentations and interactive discussions covering key issues such as current market trends, biobetters, the global regulatory environment, pricing and reimbursement strategies and biosimilars in emerging markets, participants will gain new insight and share hands-on experiences with leading companies in the pharma and biotech industry.
